Get started
Author

Rania Kasmi

Observed names: R. Kasmi, Rania KASMI
ORCID: 0000-0003-0599-9071
Observed ORCID: 0000-0003-0599-9071
OpenAlex ID: A5020691390
In silico design of novel Pyrazole derivatives containing thiourea skeleton as anti-cancer agents using: 3D QSAR, Drug-Likeness studies, ADMET prediction and molecular docking
2021 · L. El Mchichi, A. El Aissouq, et al. · Materials Today Proceedings · 46
2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method
2020 · Rania Kasmi, Elghalia Hadaji, et al. · Heliyon · 40
3D-QSAR study, docking molecular and simulation dynamic on series of benzimidazole derivatives as anti-cancer agents
2022 · L. El Mchichi, K. Tabti, et al. · Journal of the Indian Chemical Society · 32
Molecular Modeling Studies of C-Glycosylfavone Derivatives as GSK-3β Inhibitors Based on QSAR and Docking Analysis
2021 · Abdellah El Aissouq, Oussama Chedadi, et al. · Journal of Solution Chemistry · 15
QSAR and molecular docking study of quinazoline derivatives as anticancer agents using molecular descriptors
2020 · R. Kasmi, E. Hadaji, et al. · Materials Today Proceedings · 10
In Silico Drug Design: Development of New Pyrimidine-based Benzothiazole Derivatives, Selective for CDK2
2021 · Rania Kasmi, Larbi Elmchichi, et al. · Letters in Drug Design & Discovery · 5
Modeling study, 3D-QSAR and molecular docking of 9H-purine derivatives as EGFR inhibitors
2022 · Rania KASMI, Youssef EL OUARDI, et al. · Materials Today Proceedings · 3
Etude In-silico 2D, 3D QSAR et Docking moléculaire de composés organiques anti cancéreux
2022 · Rania KASMI · Toubkal
Works count: 8
Citation count: 151
H-index: 5
I10-index: 5
Year
Topic
Type